Bayer, a global enterprise in healthcare and nutrition, has launched its Imaging Core Lab Services under the new brand name Centafore. Backed by over 25 years of experience supporting 200+ clinical trials globally, within Bayer and its affiliated companies—Centafore is now positioned as an independent Imaging Contract Research Organization (iCRO).
Centafore: Tailored Imaging Solutions for Clinical Trials & SaMD
Centafore offers specialized imaging services to external pharmaceutical, biotech, medical device, and digital health companies, supporting:
- Early-stage research through Phase IV clinical trials
- Development of Software as a Medical Device (SaMD)
- Imaging analysis across diverse therapeutic areas
- Compliance with regulatory and data privacy standards
Centafore Debut at ASCO 2025
Meet the Team in Chicago
Bayer will showcase Centafore’s services and technologies at the Annual Meeting of the American Society of Clinical Oncology (ASCO) 2025, taking place in Chicago from May 30 to June 3.
Visitors will have the opportunity to:
- Meet the Centafore team
- Explore Centafore’s advanced technology
- Learn how Centafore enables better decision-making in imaging trials
Centafore delivers a robust platform of imaging capabilities, empowering study sponsors with:
- Expert project management
- Image management, processing, and interpretation
- Advanced imaging data analysis
Global Network of Imaging Experts
Centafore’s extensive network includes:
- Board-certified radiologists
- Imaging professionals with experience in over 50 countries
- Infrastructure to manage global, multi-site imaging studies
Industry Endorsement
“Centafore represents a significant leap forward in our commitment to enhancing the landscape of clinical trial imaging and advancing new medicines,”
said Nelson Ambrogio, President of Radiology at Bayer.
He emphasized Centafore’s potential to:
- Improve trial outcome reliability
- Support informed decision-making
- Benefit patients through improved quality of care
Broad Therapeutic Focus
Centafore’s services span a wide range of therapeutic areas:
- Oncology
- Cardiovascular diseases
- Central Nervous System (CNS) disorders
- Dermatology
- Women’s health
- Pediatrics
- Digital health solutions
Global Collaborations and First Appearances
Centafore was first introduced at ECR 2024 and is already collaborating with key organizations such as:
- OBIO (Ontario Bioscience Innovation Organization)
- Luxsonic Technologies
These partnerships leverage clinical imaging as a critical tool for improving decision-making in trials and SaMD development.
Bayer’s Legacy in Radiology
Bayer has been a long-standing leader in radiology, offering:
- Contrast agents and delivery devices for CT, MRI, X-ray, and PET imaging
- Informatics solutions and a curated digital marketplace featuring AI-enabled applications
Financial Performance
- Radiology product sales in 2024: €2.1 billion globally
Commitment to Future Innovation
Bayer continues to invest in:
- Cutting-edge radiology technology
- Clinical research and development
- Patient-centered solutions that improve diagnostic accuracy and outcomes
